The Hanford thyroid disease study: An alternative view of the findings

Health Physics

Volumn 92, Issue 2, 2007, Pages 99-111

  Hoffman, F Owen ^a   Ruttenber, A James ^b   Apostoaei, A Iulian ^a   Carroll, Raymond J ^c   Greenland, Sander ^d  

^a SENES Oak Ridge Incorporated   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

131I; Epidemiology; Health effects; Thyroid

Indexed keywords

IODINE 131;

DIETARY INTAKE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; ERROR; HANFORD THYROID DISEASE STUDY; HUMAN; MATHEMATICAL MODEL; METHODOLOGY; PRIORITY JOURNAL; REVIEW; SIMULATION; STATISTICAL SIGNIFICANCE; THYROID CANCER; THYROID DISEASE;

COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; NUCLEAR REACTORS; RADIATION DOSAGE; RADIATION INJURIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; WASHINGTON;

EID: 33846235133     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HP.0000237628.04320.16     Document Type: Review

References (46)

1. Apostoaei AI. Testing prediction capabilities of a 131I terrestrial transport model by using measurements collected at the Hanford nuclear facility. Health Phys 88:439-458; 2005.
2. Boice JD, Mumma MT, Blot WJ. Cancer mortality among populations residing in counties near the Hanford site, 1950-2000. Health Phys 90:431-445; 2006.
3. Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piptsevich N, Pichera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D. Risk of thyroid cancer after exposure to 131I in childhood. J Nat Cancer Inst 97:724-732; 2005.
4. Carroll RJ, Ruppert D, Stefanski LA, Crainceanu CM. Measurement error in nonlinear models: a modern perspective. Boca Raton, FL: Chapman and Hall CRC Press; 2006.
5. Davis S, Kopecky KJ, Hamilton TE, Onstad LE, King BL, Saporito MS. Hanford thyroid disease study: Final report. 2002. Available at: http://www.cdc.gov/nceh/radiation/hanford/htdsweb/. Accessed 27 Oct 2005.
6. Davis S, Kopecky KJ, Hamilton TE, Onstad LE, King BL, Saporito MS. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine-131 from the Hanford Nuclear Site. JAMA 292:2600-2613; 2004.
7. Farris WT, Napier BA, Ikenberry TA, Simpson JC, Shipler DB. Atmospheric pathway dosimetry report, 1944-1992. Richland, WA: Battelle Pacific Northwest Laboratories; PNWD-2228 HEDR; 1994.
8. Gavrilin Y, Khrouch V, Shinkarev S, Drozdovitch S, Minenko V, Shemiakina E, Ulanovsky A, Bouville A, Anspaugh L, Voillequé P, Luckyanov N. Individual thyroid dose estimation for a case-control study of Chernobyl-related thyroid cancer among children of Belarus - Part I: 131I, short-lived radioiodines (132I, 133I, 135I), and short-lived radiotelluriums (131MTe and 132Te). Health Phys 86:565-585; 2004.
9. Gilbert ES, Tarone R, Bouville A, Ron E. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests. J Nat Cancer Inst 90:1654-1660; 1998.
10. Greenland S. Multiple-bias modeling for analysis of observational data (with discussion). J Roy Statist Soc, Series A 168:267-308; 2005.
11. Heeb CM, Bates DJ. Radionuclide releases to the Columbia River from Hanford operations, 1944-1971. Richland, WA: Battelle Pacific Northwest Laboratories; PNWD2223-HEDR; 1994.
12. Hoffman FO. Peer review of HEDR uncertainty and sensitivity analyses plan. Hanford environmental dose reconstruction project. Richland, WA: Battelle Pacific Northwest Laboratories; PNWD-2162 HEDR; 1993.
13. Hoffman FO. How large can uncertainty be when models take the place of measurements? In: Ron E, Hoffman FO, eds. Uncertainties in radiation dosimetry and their impact on dose-response analysis. Bethesda, MD: NCI; NIH 99-4541; 1999.
14. Institute of Medicine/National Research Council. Exposure of the American people to iodine-131 from Nevada nuclear bomb tests. Review of the National Cancer Institute report and public health implications. Washington, DC: National Academy Press; 1999.
15. Ivanov VK, Gorski AI, Pitkevitch VA, Tsyb AF, Cardis E, Storm H. Risk of radiogenic thyroid cancer in Russia following the Chernobyl accident. In: Thomas G, Karaoglou A, Williams ED, eds. Radiation and thyroid cancer. River Edge, NJ: World Scientific Publishing; 1999.
16. Jacob P, Kenigsberg Y, Zvonova I, Goulko G, Buglova E, Heidenreich WF, Golovneva A, Bratilova AA, Dorzdovitch V, Kruk J, Pochtennaja GT, Balonov M, Demidchik EP, Paretzke HG. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 80:1461-1469; 1999.
17. Jacob P, Kenigsberg J, Likhtarev I, Tronko M, Shinkarev S, Meckbach R, Demidchik Y, Kovgan L, Bogdanova T, Ulanovski A, Gavrilin Y, Buglova E, Vavilov S, Schotola C, Kruk J, Chepurniy M, Prohl G. Thyroid exposure of Belarusian and Ukrainian children due to the Chernobyl accident and resulting thyroid cancer risk. Final report of BfS project StSch4240. Neuherberg: GSF - Forschungszenrum fur Umwelt und Gesundheit, GmbH; 2004.
18. Kerber RA, Till JE, Simon SL, Lyon LL, Thomas DC, Preston-Martin S, Ralison ML, Lloyd RD, Stevens W. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 270:2076-2082; 1993.
19. Kopecky KJ, Davis S, Hamilton TE, Saporito MS, Onstad LE. Estimation of thyroid radiation doses for the Hanford thyroid disease study: results and implications for statistical power of the epidemiologic analyses. Health Phys 87:15-32; 2004.
20. 131I from the Hanford nuclear site. Thyroid 15:604-613; 2005.
21. Kopecky KJ, Stepanenko NR, Rivkind N, Voilleque P, Onstad L, Shakhtarin V, Parshkov E, Kulikov S, Lushnikov E, Abrosimov A, Troshin V, Romanova G, Doroschenko V, Proshin A, Tsyb A, Davis S. Childhood thyroid cancer, radiation dose from Chernobyl, and dose uncertanties in Bryansk Oblast, Russia: a population-based case-control study. Rad Res 166:367-374; 2006.
22. Land C, Gilbert E, Smith J, Hoffman FO, Apostoaei IA, Thomas BA, Kocher DC. Report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables. Bethesda, MD: NIH/NCI; 2003.
23. Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lundberg L, Wallfren A. Cancer incidence after radiotherapy for skin hemangioma during infancy. Acta Oncologica 34:735-740; 1995.
24. Lubin JH, Schafer DW, Ron E, Stovall M, Carroll RJ. A reanalysis of thyroid neoplasms in the Israeli tinea capitis study accounting for dose uncertainties. Radiat Res 161:359-368; 2004.
25. Lundell M, Hakulinen T, Holm L-E. Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 140:334-339; 1994.
26. Lyon JL, Alder SC, Bishop Stone M, Scholl A, Reading JC, Holubkov R, Sheng X, White GL Jr, Hegmann KT, Anspaugh L, Hoffman FO, Simon SL, Thomas B, Carroll R, Meikle AW. Thyroid disease associated with exposure to the Nevada Nuclear Weapons Test Site radiation: A reevaluation based on corrected dosimetry and examination data. 2006. Epidemiology 17:604-614; 2006.
27. Mallick B, Hoffman FO, Carroll RJ. Semiparametric regression modeling with mixtures of Berkson and classical error, with application to fallout from the Nevada Test Site. Biometrics 58:13-20; 2002.
28. Minenko VF, Ulanovsk AV, Drozdovitch VV, Shemiakina EV, Gavrilin YI, Khrouch VT, Shinkarev SM, Voillequé PG, Bouville A, Anspaugh LR, Luckyanov NL. Individual thyroid dose estimates for a case-control study of Chernobyl-related thyroid cancer among children of Belarus - Part II. Contributions from long-lived radionuclides and external radiation. Health Phys 90:312-327; 2006.
29. National Cancer Institute. Estimated exposures and thyroid doses received by the American people from iodine-131 in fallout following Nevada atmospheric nuclear bomb tests: a report from the National Cancer Institute. Bethesda, MD: U.S. Department of Health and Human Services; 1997.
30. 131I thyroid dose/risk calculator for Nevada Test Site fallout. 2003. Available at http://ntsi131.nci.nih.gov/. Accessed 28 Oct 2005.
31. National Research Council/National Academies of Science. Review of the Hanford thyroid disease study draft final report. Washington, DC: National Academy Press; 2000.
32. National Research Council/National Academies of Science. Health risks from exposure to low levels of ionizing radiation - BEIR VII (Phase 2). A report of the Board on Radiation Effects Research. Washington, DC: National Academies Press; 2006.
33. Reeves GK, Cox DR, Darby SC, Whitley E. Some aspects of measurement error in explanatory variables for continuous and binary regression models. Statistics in Medicine 17:2157-2177; 1998.
34. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277; 1995.
35. Rothman KJ, Greenland S. Modern epidemiology, 2nd edition. Philadelphia: Lippincott Williams & Wilkins; 1998.
36. Schafer DW, Gilbert ES. Some statistical implications of dose uncertainty in radiation dose-response analyses. Rad Res 166:303-312; 2006.
37. Shakhtarin VV, Tsyb A, Stepanenko VF, Orlov MY, Kopecky KJ, Davis S. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 32:584-591; 2003.
38. Shore R. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 131:98-111; 1992.
39. Shore R, Xue X. Comparative thyroid cancer risk of childhood and adult radiation exposure and estimation of lifetime risk. In: Thomas G, Karaoglou A, Williams ED, eds. Radiation and thyroid cancer. Brussels-Luxembourg: World Scientific Publishing Ltd; 1999: 491-498.
40. Simon SI, Anspaugh LR, Hoffman FO, Scholl AE, Stone MB, Thomas BA, Lyon JL. 2004 update of dosimetry for the Utah Thyroid Cohort Study. Radiat Res 165:208-222; 2006.
41. Snyder FS, Farris WT, Napier BA, Ikenberry TA, Gilbert RO. Parameters used in the environmental pathways and radiological dose modules (DESCARTES, CIDER, and CRD codes) of the Hanford Environmental Dose Reconstruction Integrated Codes (HEDRIC). Richland, WA: Battelle Pacific Northwest Laboratories; PNWD-2023 HEDR Rev. 0; 1994.
42. Stevens W, Till JE, Thomas DC, Lyon JL, Kerber RA, Preston-Martin S, Simon SL, Rallison ML, Lloyd RD. Assessment of leukemia and thyroid disease in relation to fallout in Utah. Report of a cohort study of thyroid disease and radioactive fallout from the Nevada Test Site. Salt Lake City, UT: University of Utah Press; 1992.
43. Stram DO, Kopecky KJ. Power analysis of epidemiologic studies of radiation-related disease risk when dose estimates are based on a complex dosimetry system with an application to the Hanford thyroid disease study. Radiat Res 160:408-417; 2003.
44. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaky M, Izumi S, Preston DL. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Rad Res 137:S17-S67; 1994.
45. Tronko MD, Howe GR, Bogdanova IT, Bouville AC, Epstein OV, Brill AB, Likhtarev IA, Fink DJ, Markov VV, Greenebaum E, Olijnyk VA, Masnyk IJ, Shpak VM, McConnell RJ, Tereshchenko VP, Robbins J, Zvinchuk OV, Zablotska LB, Hatch M, Luckyanov NK, Ron E, Thomas TL, Voilleque PG, Beebe GW. A cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: thyroid cancer in Ukraine detected during first screening. J Nat Cancer Inst 98:897-903; 2006.
46. United National Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UN-SCEAR 2000 report to the general assembly, with scientific annexes. Volume I: Sources. New York: United Nations; 2000.